Appendix A: project index |
Study # |
Study Title |
Department of Defense |
|
DoD-1 |
Naval Health Study Program |
DoD-1A |
Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors; Study 1: A Study of Symptoms Among 1500 Seabees |
DoD-1B |
Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors; Study 2: A comparative study of hospitalizations among Active-duty personnel who participated in the Gulf War and similar personnel who did not. |
DoD-1C |
Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors; Study 3: A comparative study of pregnancy outcomes among Gulf war veterans and other active-duty personnel. |
DoD-1D |
Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors; Study 4: Adverse Reproductive Outcomes in Gulf War Veterans |
DoD-1E |
Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors; Study 5: Seabee Health Study. |
DoD-1F |
Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors; Study 6: A Comparison of Nonfederal Hospitalization Experience Among Veterans in California who have separated from active service: PGW vs. EV. |
DoD-1G |
Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors; Study 7: Prevalence of Congenital Anomalies Among Children of Persian Gulf War Veterans. |
DoD-2 |
Physiological and Neurobehavioral Effects in Rodents from Exposure to Pyridostigmine, Fuels, and DEET |
DoD-4 |
The General Well-Being of Gulf War Era Service Personnel from the States of Pennsylvania and Hawaii: A Survey |
DoD-6 |
Program DoD-6 |
DoD-6A |
Combat Stress Pharmacotherapy |
DoD-6B |
Combat Stress Diagnosis, PTSD Prevention |
DoD-7A |
Health Risk Assessment of Embedded Depleted Uranium: Behavior, Physiology, Histology, and Biokinetic Modeling |
DoD-7B |
Carcinogenicity of Depleted Uranium Fragments |
DoD-8 |
Program DoD-8 |
DoD-8A |
Serologic Diagnosis of Viscerotropic Leishmaniasis (VTL) |
DoD-8B |
Development of a Leishmania Skin Test Antigen (LSTA) |
DoD-9 |
Identification of the Genetic Factors Which Control Tropism in Leishmania |
DoD-10 |
Pyridostigmine Synergistic Toxicity Study |
DoD-11 |
Male/Female Differential Tolerances to Pyridostigmine Bromide |
DoD-12 |
Forward Deployable Diagnostics for Infectious Diseases |
DoD-13 |
Effects of Persian Gulf War Service on Military Working Dogs |
DoD-14 |
Risk Factors Among US Army Soldiers for Enrolling on the Department of Veterans Affairs Gulf War Registry |
DoD-15 |
Comparative Mortality Among US Military Personnel Worldwide During Operations Desert Shield and Desert Storm |
DoD-16 |
Kuwait Oil Fire Health Risk Assessment |
DoD-17 |
Retrospective Studies Involving Military Use of Pyridostigmine as a Pretreatment for Nerve Agent Poisoning |
DoD-18 |
Kuwait Oil Fires Troop Exposure Assessment Model (TEAM) |
DoD-19 |
Persian Gulf Veterans Health Tracking System |
DoD-20 |
A Statistical Study Correlating the Reported Cases of Gulf War Syndrome to Battlefield Locations of Afflicted US Army Personnel During the Iraq-Kuwait War; Part 1: Method to Related Troop Deployment and the Reported Cases of Gulf War Syndrome and Probable Incidence of Maladies Defined by ICD-9-CM |
DoD-21 |
Study of Variability In Pyridostigmine Inhibition of Blood Cholinesterases in Healthy Adults and Individuals With Symptoms Following Participation in Operation Desert Storm |
DoD-22 |
Chronic Organophosphorous Exposure and Cognition |
DoD-23 |
Acute and Long-Term Impact of Deployment to Southwest Asia on the Physical and Mental Health of Soldiers and their Families |
DoD-30 |
Epidemiological Studies Persian Gulf War Illnesses, PG Women's Health Linkage Study |
DoD-31 |
Dysregulation of the Stress Response in the Persian Gulf Syndrome |
DoD-32 |
Neuropsychological Functioning in Persian Gulf Era Veterans |
DoD-33 |
Effects of Pyridostigmine in Flinders Line Rats Differing in Cholinergic Sensitivity |
DoD-34 |
Characterization of Emissions from Heaters Burning Leaded Diesel Fuel in Unvented Tents |
DoD-35 |
Feasibility of Investigating Whether There is a Relationship Between Birth Defects and Service in the Gulf War. |
DoD-36 |
Fatigue in Persian Gulf Syndrome-Physiologic Mechanisms |
DoD-37 |
Neurobehavioral and Immunological Toxicity of Pyridostigmine, Permethrin, and DEET in Male and Female Rats |
DoD-38 |
Diagnostic Antigens of Leishmania tropica |
DoD-39 |
A Controlled Epidemiological and Clinical Study into the Effect of Gulf War Service on Servicemen and Women of the United Kingdom Armed Forces |
DoD-40 |
Psychological and Neurobiological Consequences of the Gulf War Experience |
DoD-41 |
Evaluation of Muscle Function in Persian Gulf Veterans |
DoD-42 |
The Symptomatic Persian Gulf Veterans Protocol: An Analysis of Risk Factors with an Immunologic and Neuropsychiatric Assessment |
DoD-44 |
Investigation of Seminal Plasma Hypersensitivity Reactions |
DoD-45 |
Physical and Emotional Health of Gulf War Veterans Women |
DoD-46 |
Exploratory Data Analysis with the CCEP Database |
DoD-47 |
Study of Mycoplasmal Infections in Gulf War Veterans |
DoD-48 |
Assessment of Genomic Instability via Chromosome 7 Inversion Frequency in a Gulf-War Syndrome Cohort vs Selected Control Groups |
DoD-49 |
Diagnosis and Dosimetry of Exposure to Sulfur Mustard: Development of Standard Operating Procedures and Exploratory Research on Protein Adducts |
DoD-50 |
Toxicokinetics of 0-Ethyl S-(2-Diisopropylaminoethyl) Methylphosphonothioate [(+)-VX] in Rats, Hairless Guinea Pigs and Marmosets - Identification of Metabolic Pathways |
DoD-51 |
Transgenic Engineering of Cholinesterases: Tools for Exploring Cholinergic Responses |
DoD-52 |
Female Gender and Other Potential Predictors of Functional Health Status Among Persian Gulf War Veterans |
DoD-53 |
Long-Term Effects of Subclinical Exposures to Sarin |
DoD-54 |
Assessment of Subchronic Neurobehavioral and Neuropathologic Effects in Rats |
DoD-55 |
Low-Level Exposure to GB Vapor in Air: Diagnosis/Dosimetry, Lowest Observable Effect Levels, Performance-Incapacitation, and Possible Delayed Effects |
DoD-56 |
Low-Level Sarin Neurotoxicity and Its Modulation by Pyridostigmine |
DoD-57 |
Physiologic Effects of Stress in Gulf War Veterans |
DoD-58 |
Illness Among Persian Gulf War Veterans: Case Validation Studies |
DoD-59 |
Pyridostigmine-induced Neurodegeneration: Role of neuronal Apoptosis |
DoD-60 |
Butyrylcholinesterase Genetic Variants in Persons with Gulf War Illness |
DoD-61 |
Neurophysiologic and Neuropathologic Effects in Monkeys of Low Level Exposures to Sarin, Pyridostigmine, Pesticides, and Botulinum Toxoid |
DoD-62 |
arin and Pyridostigmine Interaction under Physical Stress: Neurotoxic Effects in Mice |
DoD-63 |
PGW Veterans: Epidemiological and Clinical Evidence for Residual Organophosphate Neurotoxicity |
DoD-64 |
Individual Differences in Neurobehavioral Effects of Pyridostigmine |
DoD-65 |
Multi-disciplinary Pathophysiologic Studies of Neurotoxic Gulf War Related Syndromes Leading to Diagnosis and Treatment |
DoD-66 |
Testing for Mycoplasmal Infection Replicability of Nucleoprotein Gene Tracking and Forensic Polymerase Chain Reaction |
DoD-67 |
Antibacterial Treatment Method Based Upon the Excretion of Dead and Decaying Spherical Bacteria |
DoD-69 |
Five Year Follow-Up of Arm Personnel Exposed to Chemical Warfare Agents |
DoD-70 |
War Syndromes from 1900 to the Present: Symptom Patterns and Long-term Health Outcomes |
DoD-71 |
A Comparison of Post Deployment Hospitalization Between Vietnam and Gulf War Veterans |
DoD-72 |
Long-term Effects of Subchronic Exposure to Sarin, Alone and with Stress or Other Chemicals |
DoD-73 |
Post-deployment Morbid Stress, Behavior and Health: Developing a Model for Predicting Morbidity, Mortality, and other Adverse Outcomes |
DoD-74 |
Relationship of Stress Exposures to Health in Gulf War Veterans |
DoD-75 |
Toxic Interactions of Prophylactic Drugs and Pesticides |
DoD-76 |
Evaluations of Immunotoxicity due to Concurrent Exposure to DEET, Pyridostigmine, and JP-8 Jet Fuel |
DoD-77 |
Percutaneous Absorption of Chemical Mixtures Relevant to the Gulf War |
DoD-78 |
Experimental Models of Gulf War Syndrome |
DoD-79 |
Time Course of Stress-induced Impairment of Blood Brain Barrier |
DoD-80 |
Molecular Regulation of Corticosteroid Receptor Expression in Stress-Responsive Cells |
DoD-81 |
Immunotoxicity due to Coexposure to DEET, Pyridostigmine, and Stress |
DoD-82 |
Feasibility of Developing a Registry of PTSD Affected Veteran Sib Pairs |
DoD-83 |
Risk for Stress-related Substance Abuse: the Effects of Family History of Alcoholism |
DoD-84 |
Psychobiologic Alterations in Persian Gulf War Veterans with and without PTSD |
DoD-85 |
CNS Cytokines and CRH in Gulf War Veterans with Multiple Unexplained Symptoms |
DoD-86 |
Effects of Combat Stress on Structure and Function of the Hippocampus |
DoD-87 |
Measurement and Validation of Psychosocial Risk and Resilience Factors Accounting for Physical and Mental Health and Health-Related Quality of Life among PGWVs |
DoD-88 |
Clinical Relevance of novel Immunological Markers in PTSD |
DoD-89 |
Limbic Blood Flow and Opiate Receptor PET in Posttraumatic Stress Disorder |
DoD-90 |
SPECT Benzodiazepine Receptor and MR Imaging in PTSD |
DoD-91 |
Neurological and Circadian Substrates of PTSD-like Behaviors |
DoD-92 |
Traumatic Experiences Persistently Enhance Cue-dependent Learning: Toward an Animal Model of Chronic Stress and Posttraumatic Stress Disorder |
DoD-93 |
Troops Exposed to New Agents at Aberdeen Proving Ground - Follow Up Investigation |
Department of Health and Human Services |
|
HHS-1 |
Health Assessment of Persian Gulf War Veterans from Iowa |
HHS-2 |
Disease Cluster in a Pennsylvania Air National Guard Unit, EPI-AID 95-18 |
HHS-3 |
Biomarkers of Susceptibility and Polycyclic Aromatic Hydrocarbon (PAH) Exposure in Urine and blood Cell DNA from U.S. Army Soldiers Exposed to Kuwaiti Oil Well Fires |
HHS-4 |
Suspected Increase of Birth Defects and health Problems Among Children Born to Persian Gulf War Veterans In Mississippi |
HHS-5 |
Cognitive Function and Symptom Patterns in Persian Gulf Veterans |
HHS-6 |
Defining Gulf War Illness |
HHS-7 |
Immunotoxicity of Dermal Permethrinand Cis-Urocanic Acid |
HHS-8 |
Strategy to Identify Non-Additive Response to Chemical Mixtures |
Department of Veterans Affairs |
|
VA-1 |
Mortality Follow-up Study of Persian Gulf Veterans, First Update |
VA-2 |
National Health Survey of Persian Gulf Veterans |
VA-2A |
VA National Survey of Persian Gulf Veterans - Phase I |
VA-2B |
VA National Survey of Persian Gulf Veterans - Phase II |
VA-2C |
VA National Survey of Persian Gulf Veterans - Phase III |
VA-3 |
Use of Roster of Veterans Who Served in Persian Gulf Area |
VA-4 |
Boston Environmental Hazards Research Center Program |
VA-4Core |
Boston Environmental Hazards Research Center Program |
VA-4A |
Evaluation of Cognitive Functioning of Persian Gulf Veterans |
VA-4B |
Evaluation of Neurological Functioning in Persian Gulf Veterans |
VA-4C |
Gulf War And Vietnam Veterans Cancer Incidence Surveillance |
VA-4D |
Evaluation of Respiratory Dysfunction Among Gulf War Veterans |
VA-4E |
The Aromatic Hydrocarbon Receptor (AhR) as a Biomarker of Susceptibility |
VA-4F |
Validity of Computerized Tests |
VA-5 |
East Orange Environmental Hazards Research Center Program |
VA-5Core |
East Orange Environmental Hazards Research Center Program |
VA-5A |
Health and Exposure Survey of Persian Gulf Veterans |
VA-5B |
Physiological and Psychological Assessments of Persian Gulf Veterans |
VA-5C |
Effects of Exertion and Chemical Stress on Persian Gulf Veterans |
VA-5D |
Effects of Genetics and Stress on Responses to Environmental Toxins |
VA-6 |
Portland Environmental Hazards Research Center Program |
VA-6Core |
Core Program: Portland Environmental Hazards Research Center: Environment, Veterans Health and the Gulf War Syndrome. Core Project for Clinical and Epidemiology Research |
VA-6A |
Psychosocial, Neuropsychological and Neurobehavioral Assessment (Project I) |
VA-6B |
Clinical and Neuroendocrine Aspects of Fibromyalgia (Project II) |
VA-6C |
Neurotoxicity of Environmental Pollutants and Warfare Agents (Project III) |
VA-6D |
DNA Damage from Chemical Agents and Its Repair (Project IV) |
VA-6E |
Clinical and Epidemiology Leishmania Research |
VA-7 |
Desert Storm Reunion Survey |
VA-8 |
Psychological Test Data of Gulf War Veterans Over Time |
VA-9 |
Evaluation of Cognitive Functioning in Persian Gulf War Veterans Reporting War-related Health Problems |
VA-10 |
Memory and Attention in PTSD |
VA-11 |
Neuropsychological Functioning in Veterans |
VA-12 |
Psychological Assessment of Operation Desert Storm Returnees |
VA-13 |
Neurobehavioral Aspects of Persian Gulf Experiences: A Pilot Study |
VA-15 |
Vaccine-Mediated Immunity Against Leishmaniasis |
VA-16 |
Protective Immunity in Experimental Visceral Leishmaniasis |
VA-17 |
Immunological Evaluation of Persian Gulf Veterans |
VA-18 |
Chronic Gastrointestinal Illness in Persian Gulf Veterans |
VA-20 |
Psychological Adjustment in Operation Desert Shield/Storm Veterans |
VA-21 |
A Comparison of PTSD Symptomatology among Three Army Medical Units Involved in ODS |
VA-36 |
Stress Symptoms and Their Causal Attribution in Desert Storm Veterans |
VA-40 |
Musculoskeletal Symptoms in Gulf War Syndrome |
VA-46 |
Diarrhea in Persian Gulf Veterans: An Irritable Bowel-Like Disorder |
VA-47 |
Retrospective Verification of Mustard Gas Exposure |
VA-48 |
Cross-Sensitization as a CNS Model for Gulf War Chemical Intolerance |
VA-49 |
Sensitivity to Pyridostigmine Bromide: Persistent Neural Dysfunction |
VA-50 |
Neuropsychological Findings in a Sample of Operation Desert Storm Veterans |
VA-51 |
Psychobiological Assessment of Desert Storm Veterans |
VA-53 |
Spouses and Children Program |
VA-54 |
Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress |
VA-55 |
Antibiotic Treatment of Gulf War Veterans' Illnesses |
Department of Defense / Veterans Affairs Shared Projects |
|
VA/DoD-1D/1V |
A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans with Gulf War Illnesses |
VA/DoD-2DA/2VA |
Follow-Up Investigation of Troops Exposed to Nerve Agents at Aberdeen Proving Ground |
VA/DoD-2VB/2DB |
Patterns of Pre-Persian Gulf War Illness and Health Care Seeking, Pilot Study |
VA/DoD-2D/2V |
VA/DoD Core Funding of the Medical Follow-up Agency |